| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.082 | 0.08 |